{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:26:02Z","timestamp":1792005962947,"version":"4.4.0"},"reference-count":28,"publisher":"The Endocrine Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11,1]]},"abstract":"Abstract<\/jats:title>\n \n Context<\/jats:title>\n Acromegaly is characterized by growth hormone (GH) and insulinlike growth factor-1 (IGF-1) hypersecretion, and GH and IGF-1 play important roles in regulating body composition and glucose homeostasis.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n The purpose of our study was to investigate body composition including ectopic lipids, measures of glucose homeostasis, and gonadal steroids in patients with active acromegaly compared with age-, body mass index (BMI)\u2212, and sex-matched controls and to determine changes in these parameters after biochemical control of acromegaly.<\/jats:p>\n <\/jats:sec>\n \n Design<\/jats:title>\n Cross-sectional study of 20 patients with active acromegaly and 20 healthy matched controls. Prospective study of 16 patients before and after biochemical control of acromegaly.<\/jats:p>\n <\/jats:sec>\n \n Main Outcome Measures<\/jats:title>\n Body composition including ectopic lipids by magnetic resonance imaging\/proton magnetic resonance spectroscopy; measures of glucose homeostasis by an oral glucose tolerance test; gonadal steroids.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Patients with active acromegaly had lower mean intrahepatic lipid (IHL) and higher mean fasting insulin and insulin area under the curve (AUC) values than controls. Men with acromegaly had lower mean total testosterone, sex hormone\u2212binding globulin, and estradiol values than male controls. After therapy, homeostasis model assessment of insulin resistance, fasting insulin level, and insulin AUC decreased despite an increase in IHL and abdominal and thigh adipose tissues and a decrease in muscle mass.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Patients with acromegaly were characterized by insulin resistance and hyperinsulinemia but lower IHL compared with age-, BMI-, and sex-matched healthy controls. Biochemical control of acromegaly improved insulin resistance but led to a less favorable anthropometric phenotype with increased IHL and abdominal adiposity and decreased muscle mass.<\/jats:p>\n <\/jats:sec>","DOI":"10.1210\/jc.2017-01210","type":"journal-article","created":{"date-parts":[[2017,9,18]],"date-time":"2017-09-18T14:05:35Z","timestamp":1505743535000},"page":"4218-4225","source":"Crossref","is-referenced-by-count":62,"title":["Body Composition and Ectopic Lipid Changes With Biochemical Control of Acromegaly"],"prefix":"10.1210","volume":"102","author":[{"given":"Miriam A","family":"Bredella","sequence":"first","affiliation":[{"name":"Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Schorr","sequence":"additional","affiliation":[{"name":"Neuroendocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E","family":"Dichtel","sequence":"additional","affiliation":[{"name":"Neuroendocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu V","family":"Gerweck","sequence":"additional","affiliation":[{"name":"Neuroendocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J","family":"Young","sequence":"additional","affiliation":[{"name":"Neuroendocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whitney W","family":"Woodmansee","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts 02115"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke","family":"Swearingen","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen K","family":"Miller","sequence":"additional","affiliation":[{"name":"Neuroendocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2017,9,18]]},"reference":[{"issue":"1","key":"2020071621151890100_B1","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1210\/er.2002-0022","article-title":"Systemic complications of acromegaly: epidemiology, pathogenesis, and management","volume":"25","author":"Colao","year":"2004","journal-title":"Endocr Rev"},{"issue":"2","key":"2020071621151890100_B2","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1210\/er.2008-0027","article-title":"Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects","volume":"30","author":"M\u00f8ller","year":"2009","journal-title":"Endocr Rev"},{"key":"2020071621151890100_B3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000181579","article-title":"Growth hormone and body composition","volume":"33","author":"Bengtsson","year":"1990","journal-title":"Horm Res"},{"issue":"6","key":"2020071621151890100_B4","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1210\/jc.2007-2780","article-title":"Lower visceral and subcutaneous but higher intermuscular adipose tissue depots in patients with growth hormone and insulin-like growth factor I excess due to acromegaly","volume":"93","author":"Freda","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2020071621151890100_B5","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1210\/jcem.87.4.8364","article-title":"Cardiovascular risk factors in acromegaly before and after normalization of serum IGF-I levels with the GH antagonist pegvisomant","volume":"87","author":"Sesmilo","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2020071621151890100_B6","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","article-title":"Mechanisms for insulin resistance: common threads and missing links","volume":"148","author":"Samuel","year":"2012","journal-title":"Cell"},{"issue":"2","key":"2020071621151890100_B7","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/jmri.22226","article-title":"Comparison of 3.0 T proton magnetic resonance spectroscopy short and long echo-time measures of intramyocellular lipids in obese and normal-weight women","volume":"32","author":"Bredella","year":"2010","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"2020071621151890100_B8","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/RCT.0b013e3181cefb89","article-title":"Breath-hold 1H-magnetic resonance spectroscopy for intrahepatic lipid quantification at 3 Tesla","volume":"34","author":"Bredella","year":"2010","journal-title":"J Comput Assist Tomogr"},{"issue":"10","key":"2020071621151890100_B9","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1210\/jc.2009-0438","article-title":"Peak growth hormone-releasing hormone-arginine-stimulated growth hormone is inversely associated with intramyocellular and intrahepatic lipid content in premenopausal women with obesity","volume":"94","author":"Bredella","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2020071621151890100_B10","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1210\/jc.2013-2063","article-title":"Effects of GH on body composition and cardiovascular risk markers in young men with abdominal obesity","volume":"98","author":"Bredella","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2020071621151890100_B11","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1210\/jc.2014-2242","article-title":"No evidence of ectopic lipid accumulation in the pathophysiology of the acromegalic cardiomyopathy","volume":"99","author":"Winhofer","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2020071621151890100_B12","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1210\/jc.2015-1917","article-title":"Adipose tissue redistribution and ectopic lipid deposition in active acromegaly and effects of surgical treatment","volume":"100","author":"Reyes-Vidal","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2020071621151890100_B13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1365-2265.2001.01214.x","article-title":"Hypogonadism in patients with acromegaly: data from the multi-centre acromegaly registry pilot study","volume":"54","author":"Katznelson","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2020071621151890100_B14","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1210\/jc.2005-1326","article-title":"Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men","volume":"91","author":"Kupelian","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2020071621151890100_B15","doi-asserted-by":"crossref","first-page":"490","DOI":"10.2337\/diacare.23.4.490","article-title":"Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study","volume":"23","author":"Stellato","year":"2000","journal-title":"Diabetes Care"},{"issue":"12","key":"2020071621151890100_B16","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1210\/jc.2015-2546","article-title":"Endogenous androgens and sex hormone-binding globulin in women and risk of metabolic syndrome and type 2 diabetes","volume":"100","author":"Fenske","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2020071621151890100_B17","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1210\/jcem.82.2.3735","article-title":"Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women","volume":"82","author":"Gambacciani","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2020071621151890100_B18","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/ijo.2008.25","article-title":"Increased visceral fat and decreased energy expenditure during the menopausal transition","volume":"32","author":"Lovejoy","year":"2008","journal-title":"Int J Obes"},{"issue":"2","key":"2020071621151890100_B19","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1148\/radiol.13130375","article-title":"Ectopic and serum lipid levels are positively associated with bone marrow fat in obesity","volume":"269","author":"Bredella","year":"2013","journal-title":"Radiology"},{"issue":"5","key":"2020071621151890100_B20","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/RCT.0000000000000423","article-title":"Short- and long-term reproducibility of intrahepatic lipid quantification by 1H-MR spectroscopy and CT in obesity","volume":"40","author":"Dichtel","year":"2016","journal-title":"J Comput Assist Tomogr"},{"issue":"6","key":"2020071621151890100_B21","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/mrm.1910300604","article-title":"Estimation of metabolite concentrations from localized in vivo proton NMR spectra","volume":"30","author":"Provencher","year":"1993","journal-title":"Magn Reson Med"},{"issue":"2","key":"2020071621151890100_B22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1365-2265.2000.00910.x","article-title":"Administration of recombinant human growth hormone on alternate days is sufficient to increase whole body protein synthesis and lipolysis in growth hormone deficient adults","volume":"52","author":"Lucidi","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2020071621151890100_B23","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1210\/jcem.83.2.4545","article-title":"A dose-response study of growth hormone (GH) replacement on whole body protein and lipid kinetics in GH-deficient adults","volume":"83","author":"Lucidi","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2020071621151890100_B24","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1046\/j.1365-2265.2000.00937.x","article-title":"Effects of growth hormone administration on protein dynamics and substrate metabolism during 4 weeks of dietary restriction in obese women","volume":"52","author":"N\u00f8rrelund","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2020071621151890100_B25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1172\/JCI10583","article-title":"Cellular mechanisms of insulin resistance","volume":"106","author":"Shulman","year":"2000","journal-title":"J Clin Invest"},{"issue":"1","key":"2020071621151890100_B26","first-page":"11","article-title":"Nonalcoholic fatty liver disease","volume":"2","author":"Yu","year":"2002","journal-title":"Rev Gastroenterol Disord"},{"issue":"5 Pt 1","key":"2020071621151890100_B27","first-page":"E977","article-title":"Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo","volume":"276","author":"Szczepaniak","year":"1999","journal-title":"Am J Physiol"},{"issue":"4","key":"2020071621151890100_B28","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1210\/jc.2011-2681","article-title":"Fat content in liver and skeletal muscle changes in a reciprocal manner in patients with acromegaly during combination therapy with a somatostatin analog and a GH receptor antagonist: a randomized clinical trial","volume":"97","author":"Madsen","year":"2012","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/102\/11\/4218\/21533577\/jc.2017-01210.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/102\/11\/4218\/21533577\/jc.2017-01210.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T03:06:07Z","timestamp":1594955167000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/102\/11\/4218\/4159876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,18]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2017-01210","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,11,1]]},"published":{"date-parts":[[2017,9,18]]}}}